The paradox of disease prevention: celebrated in principle, resisted in practice.

Prevention of disease is often difficult to put into practice. Among the obstacles: the success of prevention is invisible, lacks drama, often requires persistent behavior change, and may be long delayed; statistical lives have little emotional effect, and benefits often do not accrue to the payer; avoidable harm is accepted as normal, preventive advice may be inconsistent, and bias against errors of commission may deter action; prevention is expected to produce a net financial return, whereas treatment is expected only to be worth its cost; and commercial interests as well as personal, religious, or cultural beliefs may conflict with disease prevention. Six strategies can help overcome these obstacles: (1) Pay for preventive services. (2) Make prevention financially rewarding for individuals and families. (3) Involve employers to promote health in the workplace and provide incentives to employees to maintain healthy practices. (4) Reengineer products and systems to make prevention simpler, lower in cost, and less dependent on individual action. (5) Use policy to reinforce choices that favor prevention. (6) Use multiple media channels to educate, elicit health-promoting behavior, and strengthen healthy habits. Prevention of disease will succeed over time insofar as it can be embedded in a culture of health.

[1]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[2]  E. Miller,et al.  Impact of anti-vaccine movements on pertussis control: the untold story , 1998, The Lancet.

[3]  N. Keating,et al.  Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations , 2013, Cancer.

[4]  H. Sato,et al.  Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  W. Mischel,et al.  Delay of gratification in children. , 1989, Science.

[6]  R. Hamman,et al.  Individual and community risks of measles and pertussis associated with personal exemptions to immunization. , 2000, JAMA.

[7]  E. Trinkaus Late Pleistocene adult mortality patterns and modern human establishment , 2011, Proceedings of the National Academy of Sciences.

[8]  Thomas May,et al.  'Clustering of exemptions' as a collective action threat to herd immunity. , 2003, Vaccine.

[9]  R. Jacobson,et al.  Understanding those who do not understand: a brief review of the anti-vaccine movement. , 2001, Vaccine.

[10]  R. Goetzel,et al.  Recent experience in health promotion at Johnson & Johnson: lower health spending, strong return on investment. , 2011, Health affairs.

[11]  M. A. Church EVIDENCE OF WHOOPING-COUGH-VACCINE EFFICACY FROM THE 1978 WHOOPING-COUGH EPIDEMIC IN HERTFORDSHIRE , 1979, The Lancet.

[12]  J. Frenk Bridging the divide: global lessons from evidence-based health policy in Mexico , 2006, The Lancet.